Letter to the Editor: “Proposal of the 3O (Obstruction, Ureteric Orifice, and Outcome) Subclassification System Associated with Obstructed Hemivagina and Ipsilateral Renal Anomaly (OHVIRA)” - 04/12/20
Disclosure/Conflict of Interest Statement: Dr. Jessica Shim has no conflicts of interest to disclose. Dr. Marc Laufer is the Director of the Boston Center for Endometriosis, which receives funding from the J. Willard and Alice S. Marriott Foundation. He is also on the International Advisory Board of AbbVie pharmaceuticals, an advisor for NextJane Gen, and an author for UpToDate. |
Vol 33 - N° 6
P. 708-709 - décembre 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?